represents several variant alleles leading to adverse drug reactions or altering drug efficacy. Recent progress on understanding the inter-individual variability of the CYP2C members and the functional and clinical
erosion has drawn increasing attention as risk factor for tooth damage or loss in recent years. It is a common condition in primary dentition compared to permanent dentition ... health and dietary factors, but it is…
main effective phenol compounds through UPLC-MS and their physioecological effects are in progress. Recent Publications 1.Tang Z Q, Zhang J, Yu J L, Wang C Z, Zhang
Recently, human-animal interaction is more frequently occur, animal bite injuries have become a serious and high-risk problems as the result. Oral flora can be transferred by close oral ... contact and through bites…
Very recently, CMT initiatives have begun to be embraced within the UK educational system. Yet no rigorous evaluation of these interventions within a school setting has been progressed
patchy depigmentation of skin that may become progressive over time. The etiology of the disease is far from clear. Recent experimental and clinical related evidence suggests that the vitiligo melanocytes
serial fashion. This progression is termed the âÂ?Â?atopic marchâÂ? and is considered the classical presentation of atopic disease. However, recent evidence suggests that this paradigm may not hold
uncommon causative organism of prosthetic infective endocarditis, but over the course of the recent years, the incidence of mycobacterial endocarditis significantly increased with often poor response to antimicrobial…
Recent reports demonstrating one third cases of Alzheimer’s disease progressing very rapidly, mimicking prion-based Creutzfeldt- Jakob disease (CJD) and are misdiagnosed. Altered cerebrospinal fluid biomarkers and…
reposted that conventional medical therapy does not improve the outcome of the disease; however, recent clinical studies have suggested bone marrow derived autologous mononuclear cells as a promising therapy option…
autosomal dominant disease characterized by deposition of cholesterol in the cornea, progressive opacification, and loss of visual acuity. Germline UBIAD1 variants introduce missense mutations in over 50 SCD families…
CAFs), which are key components of the tumor microenvironment driving disease progression. In this context, we have recently demonstrated that GPER is involved in breast cancer cells adaptation to hypoxic
autosomal dominant disease characterized by deposition of cholesterol in the cornea, progressive opacification, and loss of visual acuity. Germline UBIAD1 variants introduce missense mutations in over 50 SCD families…
technologies and materials. A multitude of research efforts in recent years have led to marked progress in this area, including in particular lithium-ion batteries based on organic electrodes
France, 1987), the development of minimally invasive surgery in the hepatobiliary system has been progressing, followed by Berci, Phillips (USA, 1991) who has done laparoscopic common bile duct exploration (LCBDE…
observed in the majority. Stable results in 23/271 cases (8.4%), a progressive trend and essential recurreces in 45/271 (16.9%), worsening in 4/271 cases (1.4%) were observed. Improvement ... treatment with the use of…
blood based liquid biopsies to assist with diagnosis, prognosis and monitoring of melanoma patients. Recent Publications 1. E Gray, A Reid, S Bowyer, L Calapre, K Siew, R Pearce ... tumor cells in the peripheral blood…
cornea into the shape of a cone. This disease can cause legal blindness in progressive cases. Although the incident rate varies by geographical region, literature states that keratoconus affects roughly ... general…
aqueous solutions of hydrate formers is the most recent addition. Hydrate formation from primary or secondary adsorption on minerals is in progress. The overall goals is a hydrate simulator that
mouse) is such a target. Most recently, we reported that TR3/Nur77 expression in human hepatic cancer tissues correlates well with tumor progress, suggesting that TR3 is a specific therapeutic